FABP3 was therefore suggested as a potential therapeutic target to treat ischemic and related heart diseases (202); however, the above-mentioned effects of FABP3 inhibition on fuel selection and cardiac hypertrophy must be considered. The gene discussed is FABP3; the disease is cardiac hypertrophy.